• 1. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 2. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 3. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines N-alkylpiperazines

4-Methyl-1-piperazinepropionic Acid Hydrochloride: A Comprehensive Overview

4-Methyl-1-piperazinepropionic Acid Hydrochloride (CAS No. 775349-40-1) is a chemical compound that has garnered significant attention in the fields of pharmaceutical research and organic synthesis. This compound, also referred to as Methylpiperazinepropionic Acid Hydrochloride, belongs to the class of piperazine derivatives, which are widely recognized for their diverse applications in drug development. The molecule's structure consists of a piperazine ring, a three-carbon chain, and a hydrochloric acid group, making it a versatile compound with potential therapeutic implications.

Recent studies have highlighted the importance of piperazine derivatives in modulating various biological pathways. For instance, research published in *Journal of Medicinal Chemistry* has demonstrated that 4-Methyl-1-piperazinepropionic Acid Hydrochloride exhibits promising activity in inhibiting certain enzymes associated with neurodegenerative diseases. This finding underscores the compound's potential as a lead molecule for developing treatments against conditions such as Alzheimer's disease and Parkinson's disease.

In addition to its therapeutic potential, 4-Methyl-1-piperazinepropionic Acid Hydrochloride has been explored for its role in cardiovascular drug discovery. A study conducted at the University of California, San Francisco, revealed that this compound can modulate ion channels, which are critical for regulating heart rhythm. These findings suggest that the compound could be a valuable tool in addressing arrhythmias and other cardiac disorders.

The synthesis of 4-Methyl-1-piperazinepropionic Acid Hydrochloride involves a multi-step process that typically begins with the preparation of piperazine derivatives. Researchers often employ nucleophilic substitution reactions or coupling agents to introduce the methyl and propionic acid groups onto the piperazine ring. The hydrochloric acid group is then added to achieve the final hydrochloride salt form, which enhances the compound's solubility and bioavailability.

From an analytical standpoint, 4-Methyl-1-piperazinepropionic Acid Hydrochloride can be characterized using advanced spectroscopic techniques such as nuclear magnetic resonance (NMR) and mass spectrometry (MS). These methods provide critical insights into the compound's molecular structure and purity, ensuring its suitability for pharmacological studies.

Looking ahead, the application of 4-Methyl-1-piperazinepropionic Acid Hydrochloride in drug delivery systems is an area of growing interest. Scientists are investigating its ability to act as a carrier for poorly soluble drugs, leveraging its amphiphilic properties to enhance drug absorption and efficacy. This innovative approach could revolutionize the way certain medications are administered, particularly in oncology and infectious disease treatments.

In conclusion, 4-Methyl-1-piperazinepropionic Acid Hydrochloride (CAS No. 775349-40-1) is a multifaceted compound with significant potential in pharmaceutical research. Its ability to modulate biological pathways, coupled with its favorable pharmacokinetic properties, positions it as a promising candidate for developing novel therapeutic agents. As research continues to uncover new applications for this compound, its role in advancing medical science is expected to grow exponentially.

• 27245-31-4(3-piperazin-1-ylpropanoic acid)
• 160844-41-7(b-Alanine,N-(2-aminoethyl)-N-methyl-)
• 5649-49-0(1,4-Bis(2-carboxyethyl)piperazine)
• 55480-45-0(3-(4-Methylpiperazin-1-yl)propanoic acid)
• 73338-66-6(b-Alanine,N,N-bis[2-[bis(2-carboxyethyl)amino]ethyl]-, pentapotassium salt (9CI))
• 13311-39-2(b-Alanine,N,N'-1,2-ethanediylbis[N-(2-carboxyethyl)-)
• 70920-53-5(3-4-(2-hydroxyethyl)piperazin-1-ylpropionic Acid)
• 67874-43-5(PAMAM DENDRIMER GENERATION -0.5)
• 1185303-69-8(3-(4-ethylpiperazin-1-yl)propanoic acid;dihydrochloride)
• 915923-47-6(3-(4-Methyl-1,4-diazepan-1-yl)propanoic acid)